No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	cladribine Sensitive: A1 - Approval cladribine Sensitive : A1	cladribine Sensitive: A1 - Approval cladribine Sensitive : A1
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	moxetumomab pasudotox Sensitive: A1 - Approval moxetumomab pasudotox Sensitive : A1	moxetumomab pasudotox Sensitive: A1 - Approval moxetumomab pasudotox Sensitive : A1
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	vemurafenib + rituximab Sensitive: A2 - Guideline vemurafenib + rituximab Sensitive : A2	vemurafenib + rituximab Sensitive: A2 - Guideline vemurafenib + rituximab Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	pentostatin Sensitive: A2 - Guideline pentostatin Sensitive : A2	pentostatin Sensitive: A2 - Guideline pentostatin Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	rituximab/hyaluronidase Sensitive: A2 - Guideline rituximab / hyaluronidase Sensitive : A2	rituximab/hyaluronidase Sensitive: A2 - Guideline rituximab / hyaluronidase Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2	rituximab Sensitive: A2 - Guideline rituximab Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	vemurafenib Sensitive: A2 - Guideline vemurafenib Sensitive : A2	vemurafenib Sensitive: A2 - Guideline vemurafenib Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	ibrutinib Sensitive: A2 - Guideline ibrutinib Sensitive : A2	ibrutinib Sensitive: A2 - Guideline ibrutinib Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	vemurafenib + obinutuzumab Sensitive: A2 - Guideline vemurafenib + obinutuzumab Sensitive : A2	vemurafenib + obinutuzumab Sensitive: A2 - Guideline vemurafenib + obinutuzumab Sensitive : A2
No biomarker	Hairy Cell Leukemia	No biomarker	Hairy Cell Leukemia	venetoclax Sensitive: A2 - Guideline venetoclax Sensitive : A2	venetoclax Sensitive: A2 - Guideline venetoclax Sensitive : A2

Hairy Cell Leukemia

Associations(23)

Associations
(23)